We address the problem of estimating heterogeneous treatment effects in panel data, adopting the popular Difference-in-Differences (DiD) framework under the conditional parallel trends assumption. We propose a novel doubly robust meta-learner for the Conditional Average Treatment Effect on the Treated (CATT), reducing the estimation to a convex risk minimization problem involving a set of auxiliary models. Our framework allows for the flexible estimation of the CATT, when conditioning on any subset of variables of interest using generic machine learning. Leveraging Neyman orthogonality, our proposed approach is robust to estimation errors in the auxiliary models. As a generalization to our main result, we develop a meta-learning approach for the estimation of general conditional functionals under covariate shift. We also provide an extension to the instrumented DiD setting with non-compliance. Empirical results demonstrate the superiority of our approach over existing baselines.

In recent years, both academic research and industry applications see an increased effort in using machine learning methods to measure granular causal effects and design optimal policies based on these causal estimates. Open source packages such as CausalML and EconML provide a unified interface for applied researchers and industry practitioners with a variety of machine learning methods for causal inference. The tutorial will cover the topics including conditional treatment effect estimators by meta-learners and tree-based algorithms, model validations and sensitivity analysis, optimization algorithms including policy leaner and cost optimization. In addition, the tutorial will demonstrate the production of these algorithms in industry use cases.

Policy makers often need to estimate the long-term effects of novel treatments, while only having historical data of older treatment options. We propose a surrogate-based approach using a long-term dataset where only past treatments were administered and a short-term dataset where novel treatments have been administered. Our approach generalizes previous surrogate-style methods, allowing for continuous treatments and serially-correlated treatment policies while maintaining consistency and root-n asymptotically normal estimates under a Markovian assumption on the data and the observational policy. Using a semi-synthetic dataset on customer incentives from a major corporation, we evaluate the performance of our method and discuss solutions to practical challenges when deploying our methodology.